118 related articles for article (PubMed ID: 9169646)
1. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants.
Al-Fiar FZ; Colwill R; Lipton JH; Fyles G; Spaner D; Messner H
Bone Marrow Transplant; 1997 May; 19(10):1019-22. PubMed ID: 9169646
[TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation.
Boulad F; Bromley M; Black P; Heller G; Sarafoglou K; Gillio A; Papadopoulos E; Sklar C
Bone Marrow Transplant; 1995 Jan; 15(1):71-6. PubMed ID: 7742758
[TBL] [Abstract][Full Text] [Related]
3. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients.
Katsanis E; Shapiro RS; Robison LL; Haake RJ; Kim T; Pescovitz OH; Ramsay NK
Bone Marrow Transplant; 1990 May; 5(5):335-40. PubMed ID: 2350628
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function in children after allogeneic bone marrow transplantation.
Borgström B; Bolme P
Bone Marrow Transplant; 1994 Jan; 13(1):59-64. PubMed ID: 8019454
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
Slatter MA; Gennery AR; Cheetham TD; Bhattacharya A; Crooks BN; Flood TJ; Cant AJ; Abinun M
Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
9. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
10. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
13. [Health status and late complications following allogeneic bone marrow transplantation. A review].
Tichelli A; Gratwohl A; Uhr M; Dazzi H; Hoffmann T; Stebler Gysi C; Walther E; Roth J; Hünig R; Nissen C
Schweiz Med Wochenschr; 1991 Oct; 121(41):1473-81. PubMed ID: 1947943
[TBL] [Abstract][Full Text] [Related]
14. The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans.
Kerbauy FR; Tirapelli B; Akabane H; Oliveira JS
Bone Marrow Transplant; 2009 Jun; 43(11):883-5. PubMed ID: 19079309
[No Abstract] [Full Text] [Related]
15. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel M; Kröger N; Sonnenberg S; Bornhäuser M; Krüger W; Kroschinsky F; Hänel A; Metzner B; Birkmann J; Schmid B; Hoffknecht MM; Fiedler F; Ehninger G; Zander AR
Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790
[TBL] [Abstract][Full Text] [Related]
16. Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.
Farag SS; Elder PJ; Marcucci G; Penza S; Mrozek E; Molina A; Lin T; Avalos BR; Copelan E
Bone Marrow Transplant; 2003 Jan; 31(2):87-93. PubMed ID: 12621488
[TBL] [Abstract][Full Text] [Related]
17. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG
Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125
[TBL] [Abstract][Full Text] [Related]
18. Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Bertz H; Potthoff K; Mertelsmann R; Finke J
Bone Marrow Transplant; 1997 Jun; 19(12):1169-73. PubMed ID: 9208109
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
20. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]